NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
TOP NEWS
»15/02/2010 [Company watch]
Parexel International experienced a strong growth in demand

Meanwhile, another Boston area company, Parexel International a clinical stage CRO, has experienced a strong growth in demand for its services in China. The company has upped its headcount to 1,600 from 1,000 just two years ago, its business coming from multinational big pharmas.

 
Meanwhile, another Boston area company, Parexel International a clinical stage CRO, has experienced a strong growth in demand for its services in China. The company has upped its headcount to 1,600 from 1,000 just two years ago, its business coming from multinational big pharmas. According to the company, the major advantage to doing trials in China is the large treatment-naive population that reduces the time to sign up patients. “Patient recruitment is the leading cause of delays in clinical trials. It is much quicker to attract patients in China, because access to top-notch care is limited there. It’s also easier to find patients that aren’t currently on any therapy,” said Mark Goldberg, CEO of Parexel. That is one of the reasons that conducting a clinical trial in China reduces by 50% the cost of performing a trial there.

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.